Skip to main content
. 2015 Sep 17;10:192. doi: 10.1186/s13014-015-0498-1

Table 3.

Dosimetric changes in different target volumes

Plan-0 Plan-1 Plan-2 Plan-3 Plan-4 Plan-5
PTVnx
Dmean (Gy) 71.17 ± 1.49 71.31 ± 1.44 71.41 ± 1.43 71.50 ± 1.40 71.60 ± 1.42 71.61 ± 1.44
P value 0.073 0.004 0.001 <0.001 0.001
 D95 (Gy) 67.40 ± 2.48 67.54 ± 2.32 67.64 ± 2.25 67.86 ± 2.26 68.23 ± 2.04 68.18 ± 2.17
P value 0.404 0.256 0.040 0.004 0.015
 V110 (%) 0.29 ± 0.65 0.30 ± 0.64 0.34 ± 0.75 0.29 ± 0.70 0.31 ± 0.86 0.32 ± 0.88
P value 0.447 0.102 0.990 0.887 0.852
 V95 (%) 95.97 ± 5.06 96.29 ± 4.76 96.68 ± 4.4 97.21 ± 3.77 97.72 ± 3.59 97.48 ± 4.34
P value 0.158 0.032 0.013 0.005 0.027
 HI 1.09 ± 0.03 1.09 ± 0.03 1.09 ± 0.03 1.09 ± 0.03 1.09 ± 0.03 1.09 ± 0.03
P value 0.244 0.244 0.116 0.258 0.678
 CI 0.76 ± 0.24 0.77 ± 0.24 0.78 ± 0.23 0.80 ± 0.22 0.81 ± 0.22 0.82 ± 0.21
P value 0.141 0.044 0.005 0.004 0.004
PTVnd
Dmean (Gy) 71.60 ± .08 71.51 ± 1.08 71.56 ± 1.12 71.68 ± 1.08 71.73 ± 1.25 71.81 ± 1.22
P value 0.134 0.634 0.334 0.312 0.090
 D95 (Gy) 66.43 ± 3.16 66.88 ± 3.31 66.89 ± 3.27 67.03 ± 3.27 67.27 ± 3.98 67.60 ± 3.57
P value 0.093 0.116 0.025 0.061 0.011
 V110 (%) 0.74 ± 1.43 0.70 ± 1.29 0.71 ± 1.37 0.74 ± 1.45 0.8 ± 1.66 0.76 ± 1.65
P value 0.528 0.386 0.984 0.984 0.902
 V95 (%) 95.09 ± 4.56 96.02 ± 4.21 96.02 ± 4.43 96.09 ± 4.47 96.66 ± 5.44 96.75 ± 5.85
P value 0.066 0.034 0.050 0.010 0.033
 HI 1.10 ± 0.04 1.10 ± 0.04 1.10 ± 0.04 1.10 ± 0.04 1.10 ± 0.03 1.10 ± 0.03
P value 0.282 0.159 0.056 0.186 0.150
 CI 0.80 ± 0.20 0.79 ± 0.18 0.80 ± 0.18 0.81 ± 0.18 0.82 ± 0.19 0.83 ± 0.18
P value 0.355 0.951 0.244 0.063 0.102
PTV1
Dmean (Gy) 68.06 ± 2.22 68.38 ± 2.03 68.52 ± 2.04 68.62 ± 1.96 68.69 ± 2.05 68.74 ± 2.06
P value 0.014 0.001 0.003 0.001 0.001
 D95 (Gy) 60.00 ± 4.12 60.63 ± 3.91 61.04 ± 4.11 61.08 ± 4.33 61.24 ± 4.41 61.20 ± 4.43
P value 0.146 0.020 0.004 0.017 0.009
 V95 (%) 95.58 ± 4.23 96.80 ± 2.97 96.90 ± 3.17 96.69 ± 3.73 96.79 ± 3.59 96.93 ± 3.46
P value 0.093 0.071 0.051 0.077 0.019
 HI 1.25 ± 0.03 1.25 ± 0.03 1.25 ± 0.03 1.25 ± 0.03 1.25 ± 0.03 1.25 ± 0.03
P value 0.478 0.706 0.258 0.053 0.086
 CI 0.90 ± 0.07 0.92 ± 0.05 0.93 ± 0.06 0.93 ± 0.05 0.93 ± 0.06 0.93 ± 0.06
P value 0.040 0.038 0.006 0.046 0.008
PTV2
Dmean (Gy) 60.21 ± 6.65 59.98 ± 6.73 60.07 ± 6.90 60.10 ± 6.80 60.08 ± 6.94 60.20 ± 6.64
P value 0.071 0.345 0.412 0.379 0.940
 D95 (Gy) 47.47 ± 6.42 46.73 ± 6.12 46.94 ± 6.18 46.89 ± 6.21 46.75 ± 16.1 46.61 ± 6.06
P value 0.008 0.069 0.038 0.020 0.023
 V95 (%) 92.48 ± 0.97 91.39 ± 1.10 91.74 ± 1.12 91.84 ± 0.92 91.56 ± 1.25 91.52 ± 0.52
P value 0.015 0.071 0.088 0.028 0.057
 HI 1.42 ± 0.05 1.42 ± 0.05 1.42 ± 0.05 1.42 ± 0.05 1.42 ± 0.05 1.42 ± 0.05
P value 0.334 0.229 0.167 0.173 0.130
 CI 0.87 ± 0.13 0.86 ± 0.13 0.86 ± 0.13 0.86 ± 0.13 0.86 ± 0.13 0.86 ± 0.13
P value 0.032 0.184 0.271 0.082 0.173

Difference was calculated by comparing Plan-0 and each hybrid plan

Dmean mean dose, D95 dose to 95 % of the volume, V110 percentage of the volume receiving more than 110 % of the prescription dose, V95 percentage of the volume receiving 95 % of the prescription dose, HI homogeneity index, CI conformity index